company background image
688399 logo

Jiangsu Bioperfectus Technologies SHSE:688399 Stock Report

Last Price

CN¥65.25

Market Cap

CN¥3.8b

7D

-1.8%

1Y

-26.1%

Updated

27 Mar, 2024

Data

Company Financials

Jiangsu Bioperfectus Technologies Co., Ltd.

SHSE:688399 Stock Report

Market Cap: CN¥3.8b

688399 Stock Overview

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China.

688399 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 688399 from our risk checks.

Jiangsu Bioperfectus Technologies Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiangsu Bioperfectus Technologies
Historical stock prices
Current Share PriceCN¥65.25
52 Week HighCN¥90.58
52 Week LowCN¥46.52
Beta0.93
1 Month Change15.69%
3 Month Change18.08%
1 Year Change-26.13%
3 Year Change-55.67%
5 Year Changen/a
Change since IPO18.90%

Recent News & Updates

Jiangsu Bioperfectus Technologies Co., Ltd.'s (SHSE:688399) Shares Climb 28% But Its Business Is Yet to Catch Up

Mar 25
Jiangsu Bioperfectus Technologies Co., Ltd.'s (SHSE:688399) Shares Climb 28% But Its Business Is Yet to Catch Up

Recent updates

Jiangsu Bioperfectus Technologies Co., Ltd.'s (SHSE:688399) Shares Climb 28% But Its Business Is Yet to Catch Up

Mar 25
Jiangsu Bioperfectus Technologies Co., Ltd.'s (SHSE:688399) Shares Climb 28% But Its Business Is Yet to Catch Up

Shareholder Returns

688399CN Medical EquipmentCN Market
7D-1.8%-4.1%-2.2%
1Y-26.1%-17.1%-14.8%

Return vs Industry: 688399 underperformed the CN Medical Equipment industry which returned -17.1% over the past year.

Return vs Market: 688399 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 688399's price volatile compared to industry and market?
688399 volatility
688399 Average Weekly Movement6.1%
Medical Equipment Industry Average Movement7.7%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688399 has not had significant price volatility in the past 3 months.

Volatility Over Time: 688399's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010937Guoqiang Wanghttps://www.s-sbio.com

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.

Jiangsu Bioperfectus Technologies Co., Ltd. Fundamentals Summary

How do Jiangsu Bioperfectus Technologies's earnings and revenue compare to its market cap?
688399 fundamental statistics
Market capCN¥3.82b
Earnings (TTM)-CN¥384.39m
Revenue (TTM)CN¥405.51m

9.4x

P/S Ratio

-10.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688399 income statement (TTM)
RevenueCN¥405.51m
Cost of RevenueCN¥0
Gross ProfitCN¥405.51m
Other ExpensesCN¥789.90m
Earnings-CN¥384.39m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)-6.56
Gross Margin100.00%
Net Profit Margin-94.79%
Debt/Equity Ratio9.3%

How did 688399 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.